webinar register page

Webinar banner
Anticoagulant Treatment of Cerebral Venous Thrombosis – Where are we in 2022?
Objectives:
1. Review epidemiology, clinical features and diagnosis of cerebral venous thrombosis
2. Discuss emerging data regarding treatment with DOACs with focus on the ACTION-CVT study
3. Outline clinical and research priorities regarding anticoagulation for cerebral venous thrombosis

Description:
Join Dr. Thalia Field, stroke neurologist, clinician-researcher, and expert in the management of cerebral venous thrombosis, along with AC Forum board members as they discuss current anticoagulant treatment of Cerebral Venous Thrombosis (CVT) and the long-term health effects in patients. The webinar will review the article “Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study”, which evaluated the effectiveness and safety of DOACs vs warfarin in patients with cerebral venous thrombosis.

Resource: "Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis
(ACTION-CVT): A Multicenter International Study"- https://pubmed.ncbi.nlm.nih.gov/35143325/

Presenter:
Thalia Field, MD, FRCPC, MHSc, Associate Professor, Heart and Stroke/Sauder Family Professorship of Stroke Research, University of British Columbia; Stroke Neurologist, Vancouver Stroke Program

Webinar Co-Chair Panelists:
Arthur L. Allen, PharmD, CACP, Anticoagulation Program Manager, VA Salt Lake City Health Care System
Deborah Siegal, MD, MSc, FRCPC, Associate Professor, Department of Medicine within the Division of Hematology, University of Ottawa (Moderator)

Aug 22, 2022 12:00 PM in Eastern Time (US and Canada)

* Required information
Loading